ASRV News Alert Ameriserv Financial Inc (ASRV) 3.10 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ameriserv Financial Inc (ASRV) 3.10 $ASRV

AmeriServ Financial announces dividend of USD0.01 per share for quarter
M2 - Mon Oct 20, 4:27AM CDT
The board of directors of AmeriServ Financial Inc (NASDAQ:ASRV), a holding company of subsidiaries that provide full-service banking and trust and wealth management services, approved a common stock cash dividend of USD0.01 per share, the company revealed on Friday.
ASRV: 3.10 (-0.01)

AmeriServ Financial declares $0.01 dividend
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 7:39AM CDT

ASRV: 3.10 (-0.01)

AmeriServ Financial, Inc. Declares Quarterly Common Stock Cash Dividend
PR Newswire - Fri Oct 17, 7:30AM CDT
AmeriServ Financial, Inc. (NASDAQ: ASRV) announced that its Board of Directors declared a $0.01 per share quarterly common stock cash dividend. The cash dividend is payable November 17, 2014 to shareholders of record on November 3, 2014. This cash dividend represents a 1.3% annualized yield using the October 16, 2014 closing common stock price of $3.05. For the first nine months of 2014, the Company's dividend payout ratio has approximated 27%.
ASRV: 3.10 (-0.01)

More on AmeriServ Financial Q3 results
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 7:17AM CDT

ASRV: 3.10 (-0.01)

AmeriServ Financial Reports Earnings For The Third Quarter And First Nine Months Of 2014
PR Newswire - Tue Oct 14, 7:00AM CDT
AmeriServ Financial, Inc. (NASDAQ: ASRV) reported third quarter 2014 net income available to common shareholders of $312,000, or $0.02 per diluted common share. This compares to net income available to common shareholders of $1,173,000, or $0.06 per diluted common share, reported for the third quarter of 2013. As previously disclosed on September 25, 2014, the Company's third quarter 2014 performance was negatively impacted by a $669,000 goodwill impairment charge related to its registered investment advisory subsidiary and approximately $150,000 of non-recurring expenses related to a profitability improvement project. For the nine month period ended September 30, 2014, the Company reported net income available to common shareholders of $2,116,000, or $0.11 per diluted share. This represented a 35.3% decline in earnings per share from the same nine month period in 2013 where net income available to common shareholders totaled $3,195,000 or $0.17 per diluted common share. The following table highlights the Company's financial performance for both the three and nine month periods ended September 30, 2014 and 2013:
ASRV: 3.10 (-0.01)

AmeriServ Financial, Inc. Announces Expected Third Quarter Goodwill Impairment Charge And Profitability Improvement Initiatives
PR Newswire - Thu Sep 25, 7:30AM CDT
AmeriServ Financial, Inc. (NASDAQ: ASRV) announced that it expects to record a third quarter non-cash goodwill impairment charge of approximately $675,000 related to West Chester Capital Advisors (WCCA), its registered investment advisor subsidiary. As previously disclosed in our filings with the Securities and Exchange Commission, the voluntary departure of WCCA's former CEO and the related litigation against him for violations of his employment agreement, caused disruption within the WCCA customer base during 2014. This disruption ultimately led to the loss of certain clients and a reduction in the projected earnings capacity of WCCA which caused the goodwill impairment charge. The Company remains strategically committed to its asset management subsidiary. WCCA is well integrated into our wealth management businesses and is expected to improve its earnings power with new business development in future periods.
ASRV: 3.10 (-0.01)

AmeriServ Financial Reports Earnings For The Second Quarter And First Six Months Of 2014
PR Newswire - Tue Jul 15, 7:00AM CDT
AmeriServ Financial, Inc. (NASDAQ: ASRV) reported second quarter 2014 net income available to common shareholders of $927,000, or $0.05 per diluted common share. This compares to net income available to common shareholders of $1,018,000, or $0.05 per diluted common share, reported for the second quarter of 2013. For the six month period ended June 30, 2014, the Company reported net income available to common shareholders of $1,804,000, or $0.10 per diluted share. When compared to the first six months of 2013, net income available to common shareholders was down by $218,000 or 10.8% while diluted earnings per share declined by a lesser amount of $0.01, or 9.1%, as total shares outstanding were lower in 2014 due to the success of the Company's common stock repurchase program which was completed in the second quarter of 2013. The following table highlights the Company's financial performance for both the three and six month periods ended June 30, 2014 and 2013:
ASRV: 3.10 (-0.01)

BioAdaptives, Inc. Announces Form S-1 Effective, Has Engaged Market Maker For 15c211 Filing With FINRA And DTC Eligibility
PR Newswire - Tue Jan 21, 11:45PM CST
BioAdaptives, Inc. has announced that its Form S-1 filing has become effective as of January 10, 2014. The company has engaged a FINRA broker dealer to submit its 15c211 filing with FINRA and expects to obtain a ticker symbol. Additionally, the company will also be seeking DTC eligibility shortly with The Depository Trust & Clearing Corporation (DTCC). 2,000,000 shares of BioAdaptives, Inc. stock, as noted within the Form S-1 filing, will be distributed to shareholders of HEMP, Inc. (Pink Sheets: HEMP).
ASRV: 3.10 (-0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

LAFC Turns Empty Seats Into an AI Test Case for Sports

Updated Category News Views 81

Empty seats are a lousy kind of inventory A vacant stadium seat is perishable inventory with the clock screaming at it. LAFC and AccelerAI have aimed their first co-developed AI project at that unglamorous but important problem: getting more ticket holders through the gate without simply hacking prices down at the last minute. That is a far more sensible use of artificial...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 178

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 135

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Auria, LSAS Team Up: Japan Space Frontier Beckons

Updated Category News Views 105

Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 187

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
AI Echo Study Sharpens a Difficult HFpEF Diagnosis

Updated Category News Views 88

A single echo clip may be doing more useful work than plenty of flashy healthcare AI demos. The November 2026 Journal of Cardiac Failure focus issue puts a hard number on that possibility: pairing an AI read of a routine echocardiogram clip with the H?FPEF clinical score identified 78% of patients with hemodynamically confirmed HFpEF, versus 48% with the score alone. That...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 95

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Elisity’s Texas Water Pilot Puts IonQ’s Deal in View

Updated Category News Views 189

Water-system security is not a place for chest-thumping Elisity’s role in Texas Project Watershed 250 lands on a problem that is painfully concrete: water and wastewater utilities have to keep pumps, treatment systems and plant operations running while trying to close cybersecurity gaps. That is a tougher job than selling another dashboard to a corporate IT department....

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 196

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 156

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading

Top 5 Most Recently Viewed Articles

Orion180 Unveils Innovative Customizable Flood Insurance

Updated Category News Views 177

Orion180 Launches Customizable Residential Flood Insurance Orion180 is making waves in the insurance sector by introducing its latest offering: a Residential Private Flood Insurance product designed to meet a variety of homeowner needs. Based in Melbourne, this innovative insurance leader is set to change how we approach flood insurance with a product that emphasizes...

Continue Reading
DIFD AUTO Revolutionizes Global Car Buying with Crypto Payments

Updated Category News Views 306

Transforming the Car Buying Experience with Cryptocurrency Today, as the digital landscape continues to evolve, DIFD AUTO stands at the forefront of a revolutionary shift in how consumers purchase vehicles. As a leading platform for cryptocurrency-based car transactions, DIFD AUTO allows customers around the globe to purchase brand-new, certified cars using major...

Continue Reading
Curtiss-Wright Reports Impressive Q3 Results and Outlook Boost

Updated Category News Views 102

Curtiss-Wright's Positive Financial Performance Curtiss-Wright Corporation (NYSE: CW) is a well-known global company recognized for providing highly engineered products and services. Recently, the company reported noteworthy financial results for the third quarter. The sales surged nearly 10% year-over-year, coming close to $800 million, with exceptional growth especially...

Continue Reading
Darling Ingredients Reports Q3 2024 Results Amid Challenges

Updated Category News Views 312

Third Quarter 2024 Overview Darling Ingredients Inc. today reported net income of $16.9 million, or $0.11 per diluted share for the third quarter of 2024. This represents a significant decline compared to net income of $125.0 million, or $0.77 per diluted share, in the third quarter of 2023. The notable decrease in net income is attributed to lower fat prices and reduced...

Continue Reading
Investigation Launched for Investors of Spyre Therapeutics, Inc.

Updated Category News Views 127

Investigation Launched into Spyre Therapeutics, Inc. Pomerantz LLP has announced an investigation on behalf of investors of Spyre Therapeutics, Inc., known by its stock ticker, NASDAQ: SYRE. This inquiry stems from allegations that the company, along with some of its executives and board members, may have been involved in securities fraud or engaged in other unlawful...

Continue Reading